DJ Rocket Pharmaceuticals Is Maintained at Outperform by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/RCKT/ratings
(END) Dow Jones Newswires
April 01, 2021 06:52 ET (10:52 GMT)
DJ Rocket Pharmaceuticals Price Target Raised to $66.00/Share From $61.00 by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/RCKT/ratings
(END) Dow Jones Newswires
April 01, 2021 06:52 ET (10:52 GMT)